Menu Search

Company Announcements

Latest announcements

Date and timeCompanyHeadlineSource
EQS-PVR: Adtran Holdings, Inc.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionEQS Newswire
EQS-PVR: Adtran Holdings, Inc.: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionEQS Newswire
Ipsen présente les derniers résultats d'une étude de phase II sur la corabotase, première de sa classe, concernant les rides glabellaires, montrant une durée d'effet prolongée et un niveau de satisfaction constamment élevé chez les patientsGlobeNewswire
Ipsen presents first-in-class late-breaking Phase II corabotase data in glabellar lines showing sustained duration of effect reinforced by consistently high patient satisfactionGlobeNewswire
Dr. Reddy's Laboratories Launches its Generic Semaglutide Injection in CanadaBusiness Wire
EQS-PVR: LANXESS Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionEQS Newswire
EQS-PVR: LANXESS Aktiengesellschaft: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionEQS Newswire
nVent Announces Share Repurchase AuthorizationGlobeNewswire
nVent Announces Quarterly Cash DividendGlobeNewswire
EQS-PVR: MTU Aero Engines AG: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distributionEQS Newswire
ENHERTU® (fam-trastuzumab deruxtecan-nxki) approved in the US for two new indications for patients with HER2-positive early breast cancerBusiness Wire
RNS announcements are delayed by up to an hour.
...